Pfizer stock (NYSE: PFE) recently reported its Q4 results, with revenues and earnings exceeding the street estimates. The company reported revenue of $17.8 billion and adjusted earnings of $0.63 per ...
Learn more about Pfizer Inc.'s (PFE) stock grades for Value, Momentum, Growth and Estimate Revisions and determine whether ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
We recently published a list of Jim Cramer’s Thoughts on These 5 Stocks. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other stocks that Jim Cramer ...
Zacks Investment Research on MSN
Is most-watched stock Pfizer Inc. (PFE) worth betting on now?
Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...
Pfizer stock (PFE) looks undervalued with a 6.7% dividend, easing LOE headwinds, and strong pipeline execution. Read the ...
Pfizer Inc. (NYSE:PFE) is included among the 14 Best Pharma Dividend Stocks to Buy in 2025. A medical technician wearing protective gloves and a mask mixing a biopharmaceutical solution. Pfizer Inc.
With an annual dividend yield of 6.37%, Pfizer Inc. (NYSE:PFE) is included among the 10 Best Fortune 500 Dividend Stocks to Invest in Right Now. Pfizer Inc. (NYSE:PFE) discovers, develops, ...
Looking ahead to 2030, our model projects PFE could trade at an average price of $44.45, with a potential range between $33.34 and $55.56. This represents a potential 73.2% return from today's price.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results